Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Hawkins

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Plos One|April 17, 2019
Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong KongJanet Bouttell, Jeremy Teoh, Peter K Chiu, et al.
The Cochrane Database of Systematic Reviews|April 19, 2017
Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysisFrancesca Saffioti, Kurinchi Selvan Gurusamy, Neil Hawkins, et al.
The Journal of Rheumatology|August 17, 2019
Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare CostsNeil McHugh, Áine Maguire, Ian Handel, et al.
Neurology and Therapy|June 16, 2023
Determining the Relationship Between Seizure-Free Days and Other Predictors of Quality of Life in Patients with Dravet Syndrome and Their Carers from FFA Registration StudiesAmy Pinsent, Georgie Weston, Elisabeth J Adams, et al.
Advances in Therapy|May 5, 2024
Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular AtrophyChristos Kokaliaris, Rachel Evans, Neil Hawkins, et al.
International Journal of Technology Assessment in Health Care|May 6, 2006
Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritisGerry Richardson, Neil Hawkins, Christopher James McCarthy, et al.
Plos One|February 25, 2017
The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategiesGodfather Dickson Kimaro, Sayoki Mfinanga, Victoria Simms, et al.
BMC Pulmonary Medicine|November 13, 2015
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysisDavid A Scott, Bethan Woods, Juliette C Thompson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2023
Central Venous Access Devices for the Delivery of Systemic Anticancer Therapy: An Economic EvaluationRobert Heggie, Nishant Jaiswal, Elaine McCartney, et al.
Clinical Pharmacology and Therapeutics|April 1, 2021
Prognostic Factors and Treatment-Effect Modifiers in Spinal Muscular AtrophyGiovanni Baranello, Ksenija Gorni, Monica Daigl, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Plos One|April 17, 2019
Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong KongJanet Bouttell, Jeremy Teoh, Peter K Chiu, et al.
The Cochrane Database of Systematic Reviews|April 19, 2017
Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysisFrancesca Saffioti, Kurinchi Selvan Gurusamy, Neil Hawkins, et al.
The Journal of Rheumatology|August 17, 2019
Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare CostsNeil McHugh, Áine Maguire, Ian Handel, et al.
Neurology and Therapy|June 16, 2023
Determining the Relationship Between Seizure-Free Days and Other Predictors of Quality of Life in Patients with Dravet Syndrome and Their Carers from FFA Registration StudiesAmy Pinsent, Georgie Weston, Elisabeth J Adams, et al.
Advances in Therapy|May 5, 2024
Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular AtrophyChristos Kokaliaris, Rachel Evans, Neil Hawkins, et al.
International Journal of Technology Assessment in Health Care|May 6, 2006
Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritisGerry Richardson, Neil Hawkins, Christopher James McCarthy, et al.
Plos One|February 25, 2017
The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategiesGodfather Dickson Kimaro, Sayoki Mfinanga, Victoria Simms, et al.
BMC Pulmonary Medicine|November 13, 2015
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysisDavid A Scott, Bethan Woods, Juliette C Thompson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2023
Central Venous Access Devices for the Delivery of Systemic Anticancer Therapy: An Economic EvaluationRobert Heggie, Nishant Jaiswal, Elaine McCartney, et al.
Clinical Pharmacology and Therapeutics|April 1, 2021
Prognostic Factors and Treatment-Effect Modifiers in Spinal Muscular AtrophyGiovanni Baranello, Ksenija Gorni, Monica Daigl, et al.
Pageof 11